The Role of Prox1 during Mouse Pancreas Organogenesis by Kilic Berkmen, G. (Gamze)
Propositions to the Thesis 
 
The Role of Prox1 during mouse pancreas organogenesis 
 
1) Compensatory mechanisms involving the activity of the one-cut transcription factor OC-2 may 
be partially responsible for the recovery of the endocrine phenotype in the Prox1-deficient 
pancreas. 
This Thesis; Vanhorenbeeck et al. Dev Biol 305, 685-94 (2007); Margagliottiet al. Dev Biol 311, 579-89 
(2007). 
  
2) Our proposal that the ensuing pancreatitis of Prox1
loxP/loxP
;Pdx1-Cre mice could result of 
congenital ductal alterations, bears on sufficient corroborating scientific evidence. 
This Thesis; Vonlaufen et al., J Gastroenterol Hepatol 23, 1339-48 (2008); Hue Su et al  HPB (Oxford) 8, 
264-86 (2006); Schulzke et al. Ann N Y Acad Sci 1165, 294-300 (2009); Weber et al., Lab Invest 88, 
1110-20 (2008); Zhang et al. Mech. Dev. 126: 958-973 (2009). 
 
3) The decreased size of most islets in the pancreas of Prox1
loxP/loxP
;Pdx1-Cre suggests a role for 
Prox1 in islet cell migration and/or adhesion. 
This Thesis; Sosa-Pineda et al., Nat Genet 25(3): 254-255; Papoutsi et al., Cell Tissue Res 330(2): 209-
220 (2007); Kamiya etal., Hepatology 48(1): 252-264 (2008); Wigle et al., Cell 98(6): 769-778 (1999); 
Miralles et al., J Cell Biol 143(3): 827-836 (1998); Cirulli et al., J Cell Biol 150(6): 1445-1460 (2000). 
 
4) Although Prox1 is not expressed in differentiated pancreatic exocrine cells, some of the 
developmental defects of Prox1-deficient pancreata suggest a role of this transcription factor in 
pancreatic exocrine progenitors. 
This Thesis. 
 
5) Opposite effects of the loss of Prox1 function on the cell cycle in different developing organs 
suggest tissue specific function of this transcription factor. 
Wigle et al., Nat Genet 21(3): 318-322 (1999); Dyer et al., Nat Genet 34(1): 53-58 (2003); Misra et al., 
Dev Dyn 237(2): 393-402 (2008); Sosa-Pineda et al., Nat Genet 25(3): 254-255 (2000); Kamiya et al., 
Hepatology 48(1): 252-264 (2008); Wang et al., Dev Biol 286(1): 182-194 (2005). 
 
6) In contrast to what the authors claim, poor efficiency associated with direct protein delivery 
using penetrins precludes widespread use of this method to generate pluripotent stem (PS) cells. 
Kim et al., Cell Stem Cells. 4:472-476 (2009); Zhou et al., Cell Stem Cell. 4:381-384 (2009). 
7) Before showing that hematopoietic stem cells derived from human iPS cells can be used for 
transplantation in vivo, the work of Lengerke et al. seems promising but is as yet preliminary.   
Lengerke et al., Hematopoietic Stem Cells VII: Ann.N.Y.Acad.Sci. 1176:219-227 (2009). 
 
8) The conclusion of Barth et al that Jarid2 overexpression contributes to the heart outflow tract 
phenotype of Nkx2.5 null mice is at best only partially supported by the experimental evidence.  
Barth et al., Dev. Dyn. 239:2024-2033 (2010).  
 
9) Le May et al.’s study showing that oxidative stress predisposes both sexes to diabetes in 
ERαKO mice challenges the idea of female sex-specific protection from diabetes by estradiol. 
Le May et al., Proc Natl Acad Sci U S A 103(24): 9232-9237 (2006); Wild et al., Diabetes Care 27(5): 
1047-1053 (2004); Louet et al., Curr Atheroscler Rep 6(3): 180-185 (2004). 
 
10) Johnson et al.’s proposal that the bone marrow “could be a potential source of germ cells that 
could sustain oocyte production in adulthood” is novel and interesting. However, confirmation 
that oocytes generated from bone marrow or peripheral blood can be fertilized and undergo 
proper embryonic development is necessary to validate their potential therapeutic value. 
Johnson et al., Cell 122(2): 303-315 (2005). 
 
11) You know you are from Chicago when you think 35 
ο
F (2 
ο
C) is great weather to wash your car. 
